5-YEAR PROJECTION

Financial Projections

Growth trajectory to £362M Year 5 revenue

£362M
Year 5 Revenue
Target
45%+
Gross Margin
Target
$97B+
Total Addressable
Market
145x
5-Year Revenue
Growth

5-Year Revenue Projection

Aggressive growth trajectory supported by secured programme engagement

Revenue Growth Trajectory

£2.5M
Year 1
£12M
Year 2
+380%
£48M
Year 3
+300%
£156M
Year 4
+225%
£362M
Year 5
+132%

Revenue Summary

Year Revenue Growth
Year 1 £2.5M -
Year 2 £12M 380%
Year 3 £48M 300%
Year 4 £156M 225%
Year 5 £362M 132%

5-year CAGR: ~170%

Revenue Model

Diversified revenue streams across materials sales, licensing, and contracts

Product Sales

Direct sales of advanced materials to defence primes and OEMs for integration into platforms.

Primary Revenue Driver

Licensing Fees

Technology licensing to regional manufacturers and partners for localised production.

High Margin Stream

Development Contracts

Funded R&D and customisation contracts for specific programme requirements.

Near-Term Revenue

Recurring Supply

Long-term supply agreements for programme production phases and aftermarket support.

Predictable Revenue

Key Assumptions

Critical milestones and market factors underlying projections

Partnership Assumptions

  • Y1
    LOI Conversion
    Convert KAAN and Altay LOIs to development contracts
  • Y2
    Tier 1 Prime Partnerships
    Establish supply agreements with UK/European defence primes
  • Y3
    Programme Integration
    Achieve qualified supplier status on 2+ major programmes

Operational Assumptions

  • Production Capacity Scaling
    Telford facility expansion to meet demand growth
  • Certifications Achieved
    ISO 9001 (Y1), AS9100 (Y2) for prime qualification
  • Market Penetration
    0.4% TAM capture by Year 5 ($97B+ market)

Margin Profile

High-margin advanced materials business model

45%+

Gross Margin Target

Proprietary materials technology enables premium pricing and strong gross margins.

60%+

Licensing Margins

Technology licensing provides high-margin revenue with minimal incremental cost.

20%+

EBITDA Target (Y5)

Scale benefits and operational leverage drive improving profitability.

Detailed Financial Model

The complete 5-year financial model with detailed assumptions, sensitivity analysis, unit economics, and scenario planning is available in the secure investor data room.

Monthly cash flow projections
Product-level revenue breakdown
Sensitivity analysis (bull/base/bear)
Capital requirements and use of funds

Request Data Room Access

Discuss the Investment Opportunity

Schedule a call to discuss financial projections and growth assumptions with our team.

Schedule a Call View Investment Proposition

Export Control Notice: Export of our products and technologies may require authorisation under UK Export Control legislation. Belvyon Limited is committed to full compliance with all applicable export control regulations.